182316-31-0

Ataquimast is a COX-2 inhibitor that inhibits the release of leukotrienes, TNF-α and GM-CSF. Ataquimast can be used in the study of advanced receptor-positive breast cancer[1].

[1] Kobayashi Y, et al., Highly efficient synthesis of quinoxalinone-N-oxide via tandem nitrosation/aerobic oxidative C-N bond formation. Org Lett. 2011 Dec 2;13(23):6280-3. DOI:10.1021/ol202760c